Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)

Market Cap	3.93B -22.4%
Revenue (ttm)	9.87B +5.3%
Net Income	370.38M +9.1%
EPS	0.23 +9.2%
Shares Out	n/a
PE Ratio	10.61
Forward PE	10.80
Dividend	0.06 (3.64%)
Ex-Dividend Date	Jun 12, 2026

Volume	n/a
Open	1.560
Previous Close	1.570
Day's Range	1.560 - 1.560
52-Week Range	1.560 - 2.300
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About FRA:GU5

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1997
• Employees: 27,057
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GU5

Financial Performance

In 2025, FRA:GU5's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error